Pentoxifylline Analog Shows Promise for Rare Skin Disease

by | Apr 29, 2026 | Health

Spread the love
An oral deuterated pentoxifylline analog demonstrates a favorable safety and improves clinical outcomes in adults with necrobiosis lipoidica, a phase 2 study shows.
Medscape Medical News

Written By

Written by Albert Pham, News Curator and Blogger

Related Posts

0 Comments